TRK 820

Known as: TRK-820 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2017
051019982017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Salvinorin A, TRK-820 (17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[N-methyl-trans-3-(3-furyl) acrylamido… (More)
Is this relevant?
2004
2004
The inhibitory effects of kappa-opioid receptor agonists on systemic skin scratching induced by the intravenous administration of… (More)
Is this relevant?
2004
2004
Repeated administration of micro-opioid receptor agonist, morphine induces tolerance not only to the antinociceptive effect but… (More)
Is this relevant?
2004
2004
It has been demonstrated that the newly synthesized kappa-opioid receptor agonist TRK-820, which has a unique structure that is… (More)
Is this relevant?
2003
2003
The effects of kappa-opioid receptor agonists trans-3,4-dichloro-N-(2-(1-pyrollidinyl)-cyclohexyl) benzeneacetamide ((-)-U50,488H… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The effects of the kappa-opioid receptor agonist, TRK-820, (-)-17-(cyclopropylmethyl)-3, 14beta-dihydroxy-4, 5alpha-epoxy-6beta… (More)
Is this relevant?
2001
2001
The effects of the novel kappa-opioid receptor agonist TRK-820 on the rewarding and locomotor-enhancing effects of morphine were… (More)
Is this relevant?
2001
2001
TRK-820 ((-)-17-cyclopropylmethyl-3,14b-dihydroxy-4,5a-epoxy-6b-[N-methyl-trans-3-(3-furyl)acrylamide]morphinan hydrochloride… (More)
Is this relevant?
1999
1999
TRK-820, a new type of 4,5-epoxymorphinan derivative, was investigated in vivo for antinociceptive activities and its selectivity… (More)
Is this relevant?
1999
1999
We analyzed the pharmacological properties of 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6b eta-[N-methyl-trans-3-(3… (More)
Is this relevant?